← Back to Discover
GordonMD Global Investments LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $206,658,499
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- KYVERNA THERAPEUTICS INC · COM · 501976104 · shares: $37,821,328
- PYXIS ONCOLOGY INC · COMMON STOCK · 747324101 · shares: $30,174,976
- TAYSHA GENE THERAPIES INC · COM SHS · 877619106 · shares: $24,501,508
- TEVA PHARMACEUTICAL INDS LTD · SPONSORED ADS · 881624209 · shares: $16,360,991
- VIR BIOTECHNOLOGY INC · COM · 92764N102 · shares: $13,792,695
- ALLOGENE THERAPEUTICS INC · COM · 019770106 · shares: $11,019,840
- CELLDEX THERAPEUTICS INC NEW · COM NEW · 15117B202 · shares: $10,408,381
- EDITAS MEDICINE INC · COM · 28106W103 · shares: $10,131,480
- ULTRAGENYX PHARMACEUTICAL IN · COM · 90400D108 · shares: $9,653,082
- BAUSCH PLUS LOMB CORP · COMMON SHARES · 071705107 · shares: $9,496,696
Reported holdings
16 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| KYVERNA THERAPEUTICS INC | COM | 501976104 | — | 4,244,818 shares | $37,821,328 |
| PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | — | 10,024,909 shares | $30,174,976 |
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | — | 723,185 shares | $24,501,508 |
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | — | 2,402,495 shares | $16,360,991 |
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | — | 1,353,552 shares | $13,792,695 |
| ALLOGENE THERAPEUTICS INC | COM | 019770106 | — | 5,298,000 shares | $11,019,840 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | — | 279,720 shares | $10,408,381 |
| EDITAS MEDICINE INC | COM | 28106W103 | — | 3,127,000 shares | $10,131,480 |
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | — | 289,101 shares | $9,653,082 |
| BAUSCH PLUS LOMB CORP | COMMON SHARES | 071705107 | — | 573,472 shares | $9,496,696 |
| AMGEN INC | COM | 031162100 | — | 20,212 shares | $7,319,169 |
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | — | 132,500 shares | $7,287,500 |
| SIONNA THERAPEUTICS INC | COM | 829401108 | — | 136,000 shares | $5,982,640 |
| INCYTE CORP | COM | 45337C102 | — | 43,300 shares | $4,908,488 |
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | — | 126,985 shares | $4,751,779 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 28,587 shares | $3,047,946 |